ReviewRadiographics : a review publication of the Radiological Society of North America, Inc
Interstitial Lung Abnormalities at CT: Subtypes, Clinical Significance, and Associations with Lung Cancer.
Open access · greenAbstract readReview
In one paragraph
Review in Radiographics : a review publication of the Radiological Society of North America, Inc. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.
- Diagnostic research in immune checkpoint inhibitor-related pneumonitis: a bibliometric analysis of research evolution, diagnostic focuses, and future priorities.Frontiers in oncology · 2026Pooled it
- Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement.American journal of respiratory and critical care medicine · 2025Guideline
- Trial
- Fibrotic Interstitial Lung Abnormalities on Preoperative CT Images Predict Cause-Specific Mortality after Stage I Non-Small Cell Lung Cancer Resection.Annals of surgical oncology · 2026Article
- Critical dialogue: Interstitial lung abnormalities: an evolving concept.Insights into imaging · 2026Article
- CT-guided core needle biopsy of focal pulmonary lesions with coexisting interstitial lung abnormalities: a case-control study.European radiology · 2026Article
- Prevalence of Interstitial Lung Abnormalities (ILAs) in Italian Lung Cancer Screening Programs: A Monocentric Study.Journal of clinical medicine · 2026Article
- Incidental pulmonary findings on CT in daily practice: the nodule and the interstitial lung abnormalities - what's old, what's new.La Radiologia medica · 2026Review
- Progression of interstitial lung abnormalities and its impact on mortality in patients with lung cancer resection.Chinese medical journal pulmonary and critical care medicine · 2026Article
- Integrating central-slice anatomy and MRF-mapped radiomics dynamics for lung adenocarcinoma subtyping.Quantitative imaging in medicine and surgery · 2026Article
- [Evaluation and clinical management of interstitial lung abnormalities : Position paper of the Austrian Society of Pneumology (ÖGP) and the Austrian Radiological Society (ÖRG) 2026].Wiener klinische Wochenschrift · 2026Review
- Association of automated quantified emphysema and interstitial lung abnormality with survival in non-small cell lung cancer.Insights into imaging · 2026Article
- Interstitial lung abnormalities: a mechanistic window into early fibrotic lung disease.Frontiers in medicine · 2026Review
- Current diagnosis, epidemiology, and management of interstitial lung abnormalities.Frontiers in medicine · 2026Review
- Interstitial lung abnormalities: to treat or not to treat? The hamlet dilemma.Frontiers in medicine · 2026Review
- Evaluation of the efficacy of different lung biopsy modalities in solitary pulmonary nodules.Frontiers in bioengineering and biotechnology · 2026Article
- Prognostic impacts of interstitial lung abnormalities on outcomes following resection for lung cancer.BMJ open respiratory research · 2025Article
- Homology-feature-assisted quantification of fibrotic lesions in computed tomography images: a proof of concept for CT image feature-based prediction for gene-expression-distribution.International journal of computer assisted radiology and surgery · 2025Article
- Analysis of baseline interstitial lung abnormality on the risk of checkpoint inhibitor-related pneumonitis and survival in advanced non-small cell lung cancer patients treated with first-line PD-1/PD-L1 inhibitors.Translational lung cancer research · 2025Article
- Predictive factors of fibrotic interstitial lung abnormality on high-resolution computed tomography scans: a prospective observational study.BMC pulmonary medicine · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 2 countries.
Akinori HataFrom the Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka University, 2-2, Yamadaoka, Suita, Osaka 5650871, Japan (A.H., M.Y., N.T.); Center for Pulmonary Functional Imaging, Department of Radiology (A.H., T.H., M.N., G.M.H., H.H.) and Pulmonary and Critical Care Division (G.M.H.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan (T. Hino, T. Hida); Department of Imaging, Dana Farber Cancer Institute, Boston, MA (M.N.); and Department of Environmental Health, Harvard TH Chan School of Public Health, Boston, Mass (D.C.C.).ORCID 0000-0003-1149-7094
Takuya HinoFrom the Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka University, 2-2, Yamadaoka, Suita, Osaka 5650871, Japan (A.H., M.Y., N.T.); Center for Pulmonary Functional Imaging, Department of Radiology (A.H., T.H., M.N., G.M.H., H.H.) and Pulmonary and Critical Care Division (G.M.H.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan (T. Hino, T. Hida); Department of Imaging, Dana Farber Cancer Institute, Boston, MA (M.N.); and Department of Environmental Health, Harvard TH Chan School of Public Health, Boston, Mass (D.C.C.).ORCID 0000-0002-8225-0737
Masahiro YanagawaFrom the Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka University, 2-2, Yamadaoka, Suita, Osaka 5650871, Japan (A.H., M.Y., N.T.); Center for Pulmonary Functional Imaging, Department of Radiology (A.H., T.H., M.N., G.M.H., H.H.) and Pulmonary and Critical Care Division (G.M.H.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan (T. Hino, T. Hida); Department of Imaging, Dana Farber Cancer Institute, Boston, MA (M.N.); and Department of Environmental Health, Harvard TH Chan School of Public Health, Boston, Mass (D.C.C.).ORCID 0000-0002-0911-6769
Mizuki NishinoFrom the Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka University, 2-2, Yamadaoka, Suita, Osaka 5650871, Japan (A.H., M.Y., N.T.); Center for Pulmonary Functional Imaging, Department of Radiology (A.H., T.H., M.N., G.M.H., H.H.) and Pulmonary and Critical Care Division (G.M.H.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan (T. Hino, T. Hida); Department of Imaging, Dana Farber Cancer Institute, Boston, MA (M.N.); and Department of Environmental Health, Harvard TH Chan School of Public Health, Boston, Mass (D.C.C.).ORCID 0000-0003-0275-0502
Tomoyuki HidaFrom the Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka University, 2-2, Yamadaoka, Suita, Osaka 5650871, Japan (A.H., M.Y., N.T.); Center for Pulmonary Functional Imaging, Department of Radiology (A.H., T.H., M.N., G.M.H., H.H.) and Pulmonary and Critical Care Division (G.M.H.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan (T. Hino, T. Hida); Department of Imaging, Dana Farber Cancer Institute, Boston, MA (M.N.); and Department of Environmental Health, Harvard TH Chan School of Public Health, Boston, Mass (D.C.C.).ORCID 0000-0001-9292-9869
Gary M HunninghakeFrom the Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka University, 2-2, Yamadaoka, Suita, Osaka 5650871, Japan (A.H., M.Y., N.T.); Center for Pulmonary Functional Imaging, Department of Radiology (A.H., T.H., M.N., G.M.H., H.H.) and Pulmonary and Critical Care Division (G.M.H.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan (T. Hino, T. Hida); Department of Imaging, Dana Farber Cancer Institute, Boston, MA (M.N.); and Department of Environmental Health, Harvard TH Chan School of Public Health, Boston, Mass (D.C.C.).ORCID 0000-0001-9782-2841
Noriyuki TomiyamaFrom the Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka University, 2-2, Yamadaoka, Suita, Osaka 5650871, Japan (A.H., M.Y., N.T.); Center for Pulmonary Functional Imaging, Department of Radiology (A.H., T.H., M.N., G.M.H., H.H.) and Pulmonary and Critical Care Division (G.M.H.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan (T. Hino, T. Hida); Department of Imaging, Dana Farber Cancer Institute, Boston, MA (M.N.); and Department of Environmental Health, Harvard TH Chan School of Public Health, Boston, Mass (D.C.C.).ORCID 0000-0001-9918-7327
David C ChristianiFrom the Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka University, 2-2, Yamadaoka, Suita, Osaka 5650871, Japan (A.H., M.Y., N.T.); Center for Pulmonary Functional Imaging, Department of Radiology (A.H., T.H., M.N., G.M.H., H.H.) and Pulmonary and Critical Care Division (G.M.H.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan (T. Hino, T. Hida); Department of Imaging, Dana Farber Cancer Institute, Boston, MA (M.N.); and Department of Environmental Health, Harvard TH Chan School of Public Health, Boston, Mass (D.C.C.).ORCID 0000-0002-0301-0242
Hiroto HatabuFrom the Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka University, 2-2, Yamadaoka, Suita, Osaka 5650871, Japan (A.H., M.Y., N.T.); Center for Pulmonary Functional Imaging, Department of Radiology (A.H., T.H., M.N., G.M.H., H.H.) and Pulmonary and Critical Care Division (G.M.H.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan (T. Hino, T. Hida); Department of Imaging, Dana Farber Cancer Institute, Boston, MA (M.N.); and Department of Environmental Health, Harvard TH Chan School of Public Health, Boston, Mass (D.C.C.).ORCID 0000-0003-1436-2988
Brigham and Women's Hospital · USHarvard University · US
Funding
The Boston Lung Cancer Survival CohortU01CA209414 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI David C Christiani · 2017 to 2026
$12.2MClinical Genetics and Screening for Pulmonary FibrosisR01HL130974 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GARY MATTHEW HUNNINGHAKE, Benjamin Alexander Raby · 2016 to 2026
$10.0MGenetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung AbnormalitiesR01HL135142 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MICHAEL H. CHO, GARY MATTHEW HUNNINGHAKE · 2017 to 2026
$7.7MInterstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences.R01HL111024 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI HUNNINGHAKE, GARY MATTHEW · 2013 to 2022
$6.4MAutomated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatmentR01CA203636 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI NISHINO, MIZUKI · 2017 to 2021
$2.9MEarly change in plasma tumor DNA as a patient and trial-level diagnostic in advanced lung cancerR01CA240592 · NCI · DANA-FARBER CANCER INST · PI PAWELETZ, CLOUD PETER · 2020 to 2024
$2.2MNCI NIH HHS R01 CA203636NCI NIH HHS R01 CA240592NCI NIH HHS U01 CA209414NHLBI NIH HHS R01 HL111024NHLBI NIH HHS R01 HL130974NHLBI NIH HHS R01 HL135142
Abstract
PubMed holds no abstract for this paper.
Indexed as
Lung Diseases, InterstitialLung NeoplasmsDisease ProgressionHumansLungTomography, X-Ray Computed
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.